𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of refractory, systemic lupus erythematosus–associated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide

✍ Scribed by Barbara A. Roach; Gordon J. Hutchinson

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
244 KB
Volume
36
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis

lupus patient with severe, treatment-resistant thrombocytopenia, which was successfully treated with lowdose IV bolus cyclophosphamide and prednisone after several other treatments had failed.

📜 SIMILAR VOLUMES

Usefulness of a low-dose intravenous imm
Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associated with AIDS
✍ Majluf-Cruz, Abraham; Luna-Castaños, Germán; Huitrón, Soledad; Nieto-Cisneros, L 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire

Treatment of systemic lupus erythematosu
Treatment of systemic lupus erythematosus–associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil
✍ Anil Gehi; Allison Webb; Martha Nolte; John Davis Jr. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immunologic self‐tolerance and the subsequent development of autoantibodies. These antibodies are thought to be important in relation to the clinical manifestations of the disease. One example is the de